Incivo União Europeia - norueguês - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatitt c, kronisk - antivirale midler til systemisk bruk - incivo, i kombinasjon med peginterferon alfa og ribavirin, er indisert for behandling av genotype-1, kronisk hepatitt c hos voksne pasienter med kompensert leversykdom (inkludert skrumplever):hvem er behandling naiv, som tidligere har vært behandlet med interferon alfa (pegylated eller ikke-pegylated) alene eller i kombinasjon med ribavirin, inkludert relapsers, delvise besvarelser og null-respondere.

Zydelig União Europeia - norueguês - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Xtandi União Europeia - norueguês - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Ciproxin 250 mg Noruega - norueguês - Statens legemiddelverk

ciproxin 250 mg

bayer ab - solna - ciprofloksacinhydroklorid - tablett, filmdrasjert - 250 mg

Dropizol 10 mg/ ml Noruega - norueguês - Statens legemiddelverk

dropizol 10 mg/ ml

pharmanovia a/s - morfin som opiumtinktur, standardisert - dråper, oppløsning - 10 mg/ ml

Rimactazid 150 mg / 75 mg Noruega - norueguês - Statens legemiddelverk

rimactazid 150 mg / 75 mg

sandoz - københavn - rifampicin / isoniazid - tablett, filmdrasjert - 150 mg / 75 mg

Rimstar Noruega - norueguês - Statens legemiddelverk

rimstar

sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg

Slenyto União Europeia - norueguês - EMA (European Medicines Agency)

slenyto

rad neurim pharmaceuticals eec sarl - melatonin - sleep initiation and maintenance disorders; autistic disorder - psykoleptiske - slenyto er angitt for behandling av søvnløshet hos barn og ungdom i alderen 2-18 med autism spectrum disorder (asd) og / eller smith-magenis syndrom, der sove hygieniske tiltak har vært utilstrekkelig.

Mecastrin 2 mg Noruega - norueguês - Statens legemiddelverk

mecastrin 2 mg

orifarm generics a/s - melatonin - depottablett - 2 mg

Melatonin Orifarm 3 mg Noruega - norueguês - Statens legemiddelverk

melatonin orifarm 3 mg

orifarm generics a/s - melatonin - tablett, filmdrasjert - 3 mg